{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-005075","form_type":"8-K","ticker":"EWTX","cik":"0001710072","company_name":"Edgewise Therapeutics, Inc.","filed_at":"2025-01-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.532828+00:00","generated_at":"2026-05-27T19:55:43.975701+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Edgewise Therapeutics promotes Behrad Derakhshan to COO","bullets":["Behrad Derakhshan, Ph.D., appointed Chief Operating Officer effective January 8, 2025.","Previously served as Chief Business Officer since September 2020.","Annual base salary increased from $478,400 to $520,000; target bonus raised to 45%.","No family relationships with any director or executive officer of the company."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-005075","json":"https://secwatch.observer/filing/0001104659-25-005075.json","markdown":"https://secwatch.observer/filing/0001104659-25-005075.md","text":"https://secwatch.observer/filing/0001104659-25-005075.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1710072/000110465925005075/0001104659-25-005075-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1710072/000110465925005075/tm253635d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T19:55:43.975701+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b4653c8977","claim":"Behrad Derakhshan changed role as Chief Operating Officer at Edgewise Therapeutics, Inc..","evidence_excerpt":"On January 8, 2025, the Board of Directors (the “ Board ”) of Edgewise Therapeutics, Inc. (the “ Company ”) promoted Behrad Derakhshan, Ph.D. to the role of Chief Operating Officer of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1710072/000110465925005075/0001104659-25-005075-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}